Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukemia in the chronic-phase: Results of the Japan Adult Leukemia Study Group RE-STOP219 Study
Iriyama N et al. Br J Haematol, July 2026 (epub ahead of print) – open access publication
Link to full abstract